Scarica l'app Stockscreener
65.74
2.59%
-1.75
Pre-mercato:
66.99
1.25
+1.90%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRUS Giù?
Forum
Previsione
Precedente Chiudi:
$67.49
Aprire:
$68.18
Volume 24 ore:
294.69K
Relative Volume:
0.28
Capitalizzazione di mercato:
$4.97B
Reddito:
$35.93M
Utile/perdita netta:
$-244.56M
Rapporto P/E:
-16.64
EPS:
-3.95
Flusso di cassa netto:
$-157.31M
1 W Prestazione:
-0.39%
1M Prestazione:
-1.62%
6M Prestazione:
+48.06%
1 anno Prestazione:
+22.67%
Intervallo 1D:
$65.71
$68.18
Intervallo di 1 settimana:
$62.63
$68.18
Portata 52W:
$33.19
$68.18
Merus N V Stock (MRUS) Company Profile
Nome
Merus N V
Settore
Industria
Telefono
31 030 253 8800
Indirizzo
YALELAAN 62, 3584 CM UTRECHT
Confronta MRUS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
65.74 | 4.99B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
388.94 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.38 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
443.64 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
677.32 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
308.63 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-13 | Iniziato | Piper Sandler | Overweight |
| 2025-02-07 | Iniziato | Wells Fargo | Overweight |
| 2024-11-21 | Iniziato | Goldman | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-03-28 | Iniziato | Truist | Buy |
| 2024-03-04 | Reiterato | Needham | Buy |
| 2023-11-02 | Iniziato | Canaccord Genuity | Buy |
| 2023-08-21 | Iniziato | TD Cowen | Outperform |
| 2022-08-02 | Iniziato | Stifel | Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-10 | Iniziato | Needham | Buy |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-06-07 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-08 | Iniziato | William Blair | Outperform |
| 2021-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-06-26 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-11-20 | Ripresa | Guggenheim | Buy |
| 2019-06-28 | Iniziato | ROTH Capital | Buy |
| 2019-04-12 | Ripresa | Guggenheim | Buy |
| 2019-04-03 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-03-27 | Iniziato | Berenberg | Buy |
| 2018-01-02 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-03-21 | Downgrade | Citigroup | Buy → Neutral |
| 2016-12-22 | Aggiornamento | Citigroup | Neutral → Buy |
| 2016-11-07 | Downgrade | Citigroup | Buy → Neutral |
| 2016-06-13 | Iniziato | Citigroup | Buy |
| 2016-06-13 | Iniziato | Guggenheim | Buy |
| 2016-06-13 | Iniziato | Wedbush | Outperform |
Mostra tutto
Merus N V Borsa (MRUS) Ultime notizie
Merus N.V. Reports Q2 2025 Financial Results - TipRanks
Merus N.V. stock trendline breakdownQuarterly Risk Review & Daily Price Action Insights - Newser
Momentum divergence signals in Merus N.V. chartJuly 2025 Volume & Growth Focused Stock Reports - Newser
Can volume confirm reversal in Merus N.V.Weekly Stock Analysis & Free Weekly Watchlist of Top Performers - Newser
Merus N.V. stock chart pattern explainedGap Down & High Yield Equity Trading Tips - Newser
How to escape a deep drawdown in Merus N.V.2025 Technical Overview & Free Weekly Watchlist of Top Performers - Newser
Using Bollinger Bands to evaluate Merus N.V.July 2025 Review & Weekly Breakout Watchlists - Newser
News impact scoring models applied to Merus N.V.Weekly Profit Summary & Fast Moving Stock Watchlists - Newser
US Bancorp DE Increases Stock Position in Merus N.V. $MRUS - Defense World
US Bancorp DE Boosts Holdings in Merus N.V. $MRUS - Defense World
Why Merus N.V. stock attracts strong analyst attentionRate Cut & Daily Profit Focused Screening - 선데이타임즈
Merus N.V.’s volatility index tracking explained2025 Earnings Surprises & Low Drawdown Investment Strategies - Newser
Using Python tools to backtest Merus N.V. strategiesPortfolio Value Report & Long-Term Investment Growth Plans - Newser
Is Merus N.V. reversing from oversold territoryTrade Analysis Summary & Scalable Portfolio Growth Ideas - Newser
Visual analytics tools that track Merus N.V. performanceTrade Risk Report & Safe Entry Point Identification - Newser
Is Merus N.V. attractive for institutional investors2025 Institutional Moves & Real-Time Buy Zone Alerts - classian.co.kr
Reversal indicators forming on Merus N.V. stock2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Applying Wyckoff theory to Merus N.V. stockJuly 2025 Recap & Verified Swing Trading Watchlist - Newser
PNC Financial Services Group Inc. Acquires 1,340 Shares of Merus N.V. (NASDAQ:MRUS) - Defense World
Is this a good reentry point in Merus N.V.2025 Price Action Summary & Safe Entry Trade Reports - Newser
What Fibonacci levels say about Merus N.V. reboundJuly 2025 Sector Moves & Stepwise Entry and Exit Trade Signals - Newser
Advanced analytics toolkit walkthrough for Merus N.V.Analyst Upgrade & Risk Controlled Daily Trade Plans - Newser
Regression analysis insights on Merus N.V. performanceGap Down & Detailed Earnings Play Alerts - Newser
Comparing Merus N.V. in custom built stock radarsQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
Multi asset correlation models including Merus N.V.2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
Will earnings trigger a reversal in Merus N.V.2025 Market Overview & Smart Investment Allocation Insights - Newser
Merus N.V. Recovery Likely Here’s What Data ShowsEarnings Recap Report & Free Fast Gain Swing Trade Alerts - kangso.co.kr
Merus N.V. Moves Into Bullish Territory Based on MACDJuly 2025 Setups & Low Risk High Win Rate Stock Picks - thegnnews.com
Analysts' Top Picks in Healthcare: Merus, AdaptHealth, and Travere Therapeutics - AInvest
The Bull Case For Merus (MRUS) Could Change Following Surging Revenue and Escalating Losses in Q2 2025 - simplywall.st
Merus NV stock hits all-time high at 67.59 USD By Investing.com - Investing.com South Africa
Merus NV stock hits all-time high at 67.59 USD - Investing.com
Leerink Partnrs Comments on Merus’ Q3 Earnings (NASDAQ:MRUS) - Defense World
What is HC Wainwright’s Estimate for Merus Q3 Earnings? - Defense World
How Rising Losses and Strong Cash Reserves at Merus (MRUS) Have Changed Its Investment Story - simplywall.st
Merus N.V. (NASDAQ:MRUS) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Is Merus' (MRUS) Rising Revenue and Widening Losses Changing Its Investment Story? - simplywall.st
Zurcher Kantonalbank Zurich Cantonalbank Has $563,000 Stock Holdings in Merus N.V. (NASDAQ:MRUS) - Defense World
Bank of America Securities Maintained a Buy Rating on Merus N.V (MRUS) - MSN
Merus to Present at the Canaccord Genuity 45th Annual Growth Conference - The Manila Times
Merus Showcases Revolutionary Cancer Treatment Platform at Major Growth Conference: CEO Presentation Details - Stock Titan
Merus to sustain operations through 2028 with $892 million in cash and equivalents. - AInvest
Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - The Manila Times
Merus sees cash runway at least into 2028 - TipRanks
Merus N.V. (MRUS) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Merus reports Q2 EPS ($2.23), consensus ($1.15) - TipRanks
Merus (MRUS) Q2 Revenue Falls Short of Expectations, Exciting Cl - GuruFocus
Merus N.V. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Envestnet Asset Management Inc. Makes New $589,000 Investment in Merus N.V. (NASDAQ:MRUS) - Defense World
Merus N.V. Forms Bullish Flag — Upside AheadTop Performing Stock Insights Released Daily - metal.it
Merus Awards Massive $15.7M Stock Options Package to Key New Hires in Oncology Push - Stock Titan
Merus N V Azioni (MRUS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Merus N V Azioni (MRUS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Silverman Peter B. | COO & GC |
Jul 17 '25 |
Sale |
60.00 |
25,000 |
1,500,000 |
0 |
1.38%
0.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):